Intravenous analgesics for post-operative pain: patterns of use in high-risk populations

{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"M/F patients, >=18 years, have an ASA score of level 3 or 4 and having undergone a surgical intervention, including coeloscopy, excluding cardiac surgery and neurosurgery, requiring antalgic treatment through IV in order to relieve postoperative pain.\nPatients having at least one of the following risk factors: aged ≥ 65 years, OCPD including sleep apnea, high blood pressure, kidney, heart or liver failure.","clusion_E":""}